Mitchell A. Jackson, MD, is the founder and CEO of Jacksoneye, his private practice of 27 years, located in Lake Villa, Illinois. He graduated from Pomona College, completed his medical training at FUHS/The Chicago Medical School, and completed his ophthalmology residency at the University of Chicago hospitals. He serves on the editorial boards of Cataract and Refractive Surgery Today, Ophthalmology Management, Advanced Ocular Care, and Ocular Surgery News. Dr Jackson is also a board member of the American College of Eye Surgeons (ACES), founding member of the American College of Ophthalmic Surgeons (ACOS), and founding member and past 2018 President of the Cataract External Disease and Refractive Surgery Society (CEDARS/ASPENS).
In addition to being selected to the PS250 Premier Surgeon list, OSN300 Refractive Surgeon list, and ASCRS clinical subcommittee for cataract and refractive surgery, Dr Jackson has been involved in many FDA pharmaceutical and surgical clinical studies (dry eye, viscoelastics, IOLs, presbyopia, topical NSAIDs) over the tenure of his practice, including serving as the Global Medical Director of ACE Vision Group. He also has his own monthly column entitled “The Premium Channel” in Ocular Surgery News/Healio, which launched in April 2013. He recently was the recipient of the 2018 Annual Millennial Award, the AAO Board of Trustees Achievement Award in August 2018, the 2018 Innovation and Founders Award for Cedars Aspens, and the 2020 Albert Nelson Marquis Lifetime Achievement Award for Ophthalmology.